ArticleAnnals of hematology2024

Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study.

Lei Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.